Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$72,616,635
+$2,847,954 QoQ
Shares Held
565,110
-2.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#252
of 3,789 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. MRK ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $72,616,635 | 565,110 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $69,768,681 | 580,004 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $62,694,540 | 595,616 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $52,045,832 | 620,110 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $50,659,629 | 639,965 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $68,896,993 | 767,569 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $77,741,133 | 781,475 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,968,459 | 774,643 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $98,207,197 | 793,273 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $80,858,432 | 612,796 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $69,178,313 | 634,547 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $66,628,004 | 647,188 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $76,571,534 | 663,589 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $74,105,422 | 696,545 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $78,139,976 | 704,281 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $61,695,592 | 716,391 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $66,073,998 | 724,734 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $56,406,831 | 687,469 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $42,771,787 | 558,087 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $42,943,241 | 571,738 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $45,654,645 | 587,047 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $46,483,213 | 602,973 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $50,260,596 | 614,433 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $53,193,702 | 641,274 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $51,049,112 | 660,146 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $50,492,623 | 656,260 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||